{"DataElement":{"publicId":"6779705","version":"1","preferredName":"Person Histologically Or Cytopathology Thyroid Gland Carcinoma Confirmation Type","preferredDefinition":"The use of histological or cytopathology to identify the type of carcinoma arising from thyroid gland carcinoma.","longName":"PER_HIST_CYTO_THYD_GLD_TP","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6779625","version":"1","preferredName":"Person Histologically Or Cytopathology Thyroid Gland Carcinoma Confirmation","preferredDefinition":"A human being._Involving the use of histology or histological techniques._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A branch of pathology that studies and diagnoses diseases on the cellular level including the anatomy, physiology, pathology and chemistry of the cell._A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and undifferentiated (anaplastic) carcinoma._Having been established or verified.","longName":"2236731v1.0:6780274v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6780274","version":"1","preferredName":"Histologically Or Cytopathology Thyroid Gland Carcinoma Confirmation","preferredDefinition":"Involving the use of histology or histological techniques.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:A branch of pathology that studies and diagnoses diseases on the cellular level including the anatomy, physiology, pathology and chemistry of the cell.:A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and undifferentiated (anaplastic) carcinoma.:Having been established or verified.","longName":"6780274v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologically","conceptCode":"C25527","definition":"Involving the use of histology or histological techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cytopathology","conceptCode":"C20611","definition":"A branch of pathology that studies and diagnoses diseases on the cellular level including the anatomy, physiology, pathology and chemistry of the cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Thyroid Gland Carcinoma","conceptCode":"C4815","definition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B1F798F-FF96-48D0-E053-F662850A7270","latestVersionIndicator":"Yes","beginDate":"2019-06-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-12","modifiedBy":"ONEDATA","dateModified":"2019-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B112BD9-DEDB-51A4-E053-F662850A8881","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"SOKKERL","dateModified":"2019-06-14","changeDescription":"6/11/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6779701","version":"1","preferredName":"Thyroid Gland Carcinoma Type","preferredDefinition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and undifferentiated (anaplastic) carcinoma._Something distinguishable as an identifiable class based on common qualities.","longName":"6779701v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Thyroid, NOS","valueDescription":"Thyroid, NOS","ValueMeaning":{"publicId":"6779703","version":"1","preferredName":"Thyroid, NOS","longName":"6779703","preferredDefinition":"An area of the thyroid gland not otherwise specified. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid, NOS","conceptCode":"C160209","definition":"An area of the thyroid gland not otherwise specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B112C4C-798F-3C1F-E053-F662850A5A6E","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"SOKKERL","dateModified":"2019-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B112C4C-79AA-3C1F-E053-F662850A5A6E","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","deletedIndicator":"No"},{"value":"Thyroid Gland Papillary Carcinoma","valueDescription":"Thyroid Gland Papillary Carcinoma","ValueMeaning":{"publicId":"4264948","version":"1","preferredName":"Thyroid Gland Papillary Carcinoma","longName":"4264948","preferredDefinition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.  Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Papillary Carcinoma","conceptCode":"C4035","definition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-38ED-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B112C4C-79BE-3C1F-E053-F662850A5A6E","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","deletedIndicator":"No"},{"value":"Thyroid Gland Follicular Carcinoma","valueDescription":"Thyroid Gland Follicular Carcinoma","ValueMeaning":{"publicId":"6779704","version":"1","preferredName":"Thyroid Gland Follicular Carcinoma","longName":"6779704","preferredDefinition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  The nuclear features which characterise the thyroid gland papillary carcinoma are absent.  It is linked to radiation and comprises approximately 10% to 15% of thyroid cancers.  Clinically, it usually presents as a solitary mass in the thyroid gland.  It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound and fine needle biopsy. Treatment options include: partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Follicular Carcinoma","conceptCode":"C8054","definition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  The nuclear features which characterize the thyroid gland papillary carcinoma are absent.  Radiation exposure is a risk factor and it comprises approximately 10% to 15% of thyroid cancers.  Clinically, it usually presents as a solitary mass in the thyroid gland.  It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B112C4C-79C9-3C1F-E053-F662850A5A6E","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B112C4C-79E2-3C1F-E053-F662850A5A6E","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","deletedIndicator":"No"},{"value":"Thyroid Gland Hurthle (Oncocytic) Cell Neoplasm","valueDescription":"Thyroid Gland Oncocytic Neoplasm","ValueMeaning":{"publicId":"4722737","version":"1","preferredName":"Thyroid Gland Oncocytic Neoplasm","longName":"4722737","preferredDefinition":"An adenoma or carcinoma arising from the follicular cells of the thyroid gland.  It is composed of large oncocytic cells with abundant granular eosinophilic cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Oncocytic Neoplasm","conceptCode":"C46068","definition":"An adenoma or carcinoma arising from the follicular cells of the thyroid gland.  It is composed of large oncocytic cells with abundant granular eosinophilic cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1F5E-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B112C4C-79F6-3C1F-E053-F662850A5A6E","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6779700","version":"1","preferredName":"Thyroid Gland Carcinoma Type","preferredDefinition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and undifferentiated (anaplastic) carcinoma.:Something distinguishable as an identifiable class based on common qualities.","longName":"C4815:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Carcinoma","conceptCode":"C4815","definition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B112C4C-7962-3C1F-E053-F662850A5A6E","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B112C4C-7973-3C1F-E053-F662850A5A6E","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"SOKKERL","dateModified":"2019-08-13","changeDescription":"6/11/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histology/cytopathology","type":"Preferred Question Text","description":"Histology/cytopathology","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B11BE5C-A6A1-65E2-E053-F662850A3807","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"SOKKERL","dateModified":"2019-06-14","changeDescription":"6/11/19ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}